Company
Lumora MD
Lumora MD publishes compounded tirzepatide, from $325 to $345 a month.
- 2 programs
- 1 molecule
- 2 readings
Read from lumoramd.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Lumora MD
We earn nothing from this link. Lumora MD has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Tirzepatide + Glycine, standard (subcutaneous injectable, weekly)
first month, including the required fees on record · Tirzepatide Sublingual/Oral Drops, 1-month
Terms
| States | Not disclosed as of September 3, 2026 |
|---|
Not yet checked: pharmacy, membership and consultation fee.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Text fetcher found nothing at /pricing, /weight-loss, /semaglutide (all 404); the real catalog lives under /medications/. This is the richest recovery in the batch: separate priced product pages for semaglutide and tirzepatide in sublingual/oral-drop form (1, 2, and 3-month supply tiers) AND separate subcutaneous-injectable variants combined with B12 or glycine (5 dose tiers for semaglutide, 6 for tirzepatide, each with its own price, not fully enumerated here). Both drugs are explicitly called 'compounded' ('This formulation combines compounded semaglutide...'). The injectable variants are described only as 'subcutaneous injectable' — never 'vial' — so form is left not-disclosed for those; the drops variants are explicitly 'Sublingual/Oral Drops'.
Before you act
Cite this
Treatment Registry. (2026). Lumora MD: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/lumora-md